Skip to main content
Erschienen in: European Journal of Pediatrics 6/2018

02.04.2018 | Original Article

The viability of probiotics in water, breast milk, and infant formula

verfasst von: Claire Watkins, Kiera Murphy, Eugene M. Dempsey, Brendan P. Murphy, Paul W. O’Toole, R. Paul Ross, Catherine Stanton, C. Anthony Ryan

Erschienen in: European Journal of Pediatrics | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to determine bacteriological stability of a probiotic mixture dispersed in various diluents. The commercially available probiotic (Infloran®), containing Bifidobacterium bifidum (109 CFU/250 mg tablet) and Lactobacillus acidophilus (109 CFU/250 mg tablet), was dispersed within expressed breast milk, sterile water, and infant formula and examined at temperatures of 4 and 21 °C. When stored at 4 °C, significant decreases (P < 0.05) in the level of L. acidophilus and B. bifidum were observed in expressed breast milk and sterile water after a 6-h period. However, when stored in infant formula, both strains remained stable over a 12-h period. When stored at 21 °C, a significant decrease (P < 0.05) was observed in the level of L. acidophilus in sterile water, expressed breast milk and infant formula throughout a 12-h period. However, no significant decrease was observed overtime in B. bifidum in all three diluents at this temperature.
Conclusion: Our findings suggest that, when stored at 4 °C, this probiotic product can remain at a stable condition for 6 h in sterile water and infant formula; however, the viability of the probiotic decreases significantly after this period of time. Administration of this probiotic in sterile water can be an acceptable alternative to dispersion and administration in expressed breast milk.
What is Known:
Administration of probiotics containing lactobacilli and bifidobacteria has become more widespread in neonatology, mainly as prophylaxis for the prevention of necrotising entercolitis in preterm infants.
Probiotic reconstitution, from its powder base, is not standardized and various diluents, including sterile water, breast milk, and infant formula, have been used.
What is New:
When stored at 4 °C, a probiotic containing lactobacilli and bifidobacteria remains at a stable microbological condition for up to 6 h in sterile water.
Administration of this probiotic dispersed in sterile water, followed by an EBM feed, can be an acceptable alternative to dispersion and administration in EBM.
Literatur
1.
Zurück zum Zitat Collado MC, Sanz Y (2006) Method for direct selection of potentially probiotic Bifidobacterium strains from human feces based on their acid-adaptation ability. J Microbiol Methods 66(3):560–563CrossRefPubMed Collado MC, Sanz Y (2006) Method for direct selection of potentially probiotic Bifidobacterium strains from human feces based on their acid-adaptation ability. J Microbiol Methods 66(3):560–563CrossRefPubMed
2.
Zurück zum Zitat Corcoran BM, Stanton C, Fitzgerald GF, Ross RP (2005) Survival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugars. Appl Environ Microbiol 71(6):3060–3067CrossRefPubMedPubMedCentral Corcoran BM, Stanton C, Fitzgerald GF, Ross RP (2005) Survival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugars. Appl Environ Microbiol 71(6):3060–3067CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Deshpande G, Rao S, Patole S, Bulsara M (2010) Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125:921–930CrossRefPubMed Deshpande G, Rao S, Patole S, Bulsara M (2010) Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125:921–930CrossRefPubMed
5.
Zurück zum Zitat Deshpande G, Rao SC, Patole S (2015) Probiotics in neonatal intensive care—back to the future. Aust N Z J Obstet Gynaecol 55(3):210–217CrossRefPubMed Deshpande G, Rao SC, Patole S (2015) Probiotics in neonatal intensive care—back to the future. Aust N Z J Obstet Gynaecol 55(3):210–217CrossRefPubMed
6.
Zurück zum Zitat Hoyert DL, Jiaquan X Deaths: preliminary data for 2011—selected causes. Natl Vital Stat Rep 6:40–42 Hoyert DL, Jiaquan X Deaths: preliminary data for 2011—selected causes. Natl Vital Stat Rep 6:40–42
7.
Zurück zum Zitat Larsen N, Vogensen FK, Gøbel R, Michaelsen KF, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M (2011) Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07. FEMS Microbiol Ecol 75(3):482–496CrossRefPubMed Larsen N, Vogensen FK, Gøbel R, Michaelsen KF, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M (2011) Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07. FEMS Microbiol Ecol 75(3):482–496CrossRefPubMed
8.
Zurück zum Zitat Macfarlane S, Macfarlane GT (2003) Regulation of short-chain fatty acid production. Proc Nutr Soc 62:67–72CrossRefPubMed Macfarlane S, Macfarlane GT (2003) Regulation of short-chain fatty acid production. Proc Nutr Soc 62:67–72CrossRefPubMed
9.
Zurück zum Zitat Shigwedha N and Jia L (2013) Bifidobacterium in human GI tract: screening, isolation, survival and growth kinetics in simulated gastrointestinal conditions. In Lactic Acid Bacteria-R & D for Food, Health and Livestock Purposes. InTech. doi: 10.5772/50457 Shigwedha N and Jia L (2013) Bifidobacterium in human GI tract: screening, isolation, survival and growth kinetics in simulated gastrointestinal conditions. In Lactic Acid Bacteria-R & D for Food, Health and Livestock Purposes. InTech. doi: 10.5772/50457
10.
Zurück zum Zitat Tarnow-Mordi WO, Wilkinson D, Trivedi A, Brok J (2010) Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice. Pediatrics 125:1068–1070CrossRefPubMed Tarnow-Mordi WO, Wilkinson D, Trivedi A, Brok J (2010) Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice. Pediatrics 125:1068–1070CrossRefPubMed
11.
Zurück zum Zitat Wang Y, Hoenig JD, Malin KJ, Malin KJ, Qamar S, Petrof OE, Sun J, Antonopoulos AD, Chang EB, Claud EC (2009) 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 3:944–954CrossRefPubMedPubMedCentral Wang Y, Hoenig JD, Malin KJ, Malin KJ, Qamar S, Petrof OE, Sun J, Antonopoulos AD, Chang EB, Claud EC (2009) 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 3:944–954CrossRefPubMedPubMedCentral
Metadaten
Titel
The viability of probiotics in water, breast milk, and infant formula
verfasst von
Claire Watkins
Kiera Murphy
Eugene M. Dempsey
Brendan P. Murphy
Paul W. O’Toole
R. Paul Ross
Catherine Stanton
C. Anthony Ryan
Publikationsdatum
02.04.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 6/2018
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-018-3133-y

Weitere Artikel der Ausgabe 6/2018

European Journal of Pediatrics 6/2018 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.